Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cells.
Young KS, Hancock GR, Fink EC, Zigrossi A, Flowers B, Cooper DA, Nguyen VT, Martinez MC, Mon KS, Bosland M, Zak DR, Runde AP, Sharifi MN, Kastrati I, Minh DDL, Kregel S, Fanning SW. Young KS, et al. Among authors: bosland m. Breast Cancer Res. 2025 Jan 17;27(1):10. doi: 10.1186/s13058-024-01945-z. Breast Cancer Res. 2025. PMID: 39825366
Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S ESR1 Mutant Breast Cancer Cells.
Young KS, Hancock GR, Fink E, Zigrossi A, Flowers B, Cooper DA, Nguyen VT, Martinez M, Mon KS, Bosland M, Zak D, Runde A, Sharifi MN, Kastrati I, Minh DDL, Kregel S, Fanning SW. Young KS, et al. Among authors: bosland m. Res Sq [Preprint]. 2024 Jun 25:rs.3.rs-4542467. doi: 10.21203/rs.3.rs-4542467/v1. Res Sq. 2024. PMID: 38978585 Free PMC article. Preprint.
Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S ESR1 Mutant Breast Cancer Cells.
Young KS, Hancock GR, Fink E, Zigrossi A, Flowers B, Cooper DA, Nguyen VT, Martinez M, Mon KS, Bosland M, Zak D, Runde A, Sharifi MN, Kastrati I, Minh DDL, Kregel S, Fanning SW. Young KS, et al. Among authors: bosland m. bioRxiv [Preprint]. 2024 Jun 2:2024.05.28.596307. doi: 10.1101/2024.05.28.596307. bioRxiv. 2024. PMID: 38854123 Free PMC article. Preprint.
Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against TMPRSS2-ERG (Fusion)-Driven and Non-Fusion-Driven Prostate Cancer.
Raina K, Kandhari K, Kant R, Prasad RR, Mishra N, Maurya AK, Fox JT, Sei S, Shoemaker RH, Bosland MC, Maroni P, Agarwal C, Agarwal R. Raina K, et al. Among authors: bosland mc. Cancers (Basel). 2023 Oct 19;15(20):5054. doi: 10.3390/cancers15205054. Cancers (Basel). 2023. PMID: 37894421 Free PMC article.
DESIGNER fraction concept unmasks minor bioactive constituents in red clover (Trifolium pratense L.).
Hitzman R, Malca-Garcia GR, Howell C, Park HY, Friesen JB, Dong H, Dunlap T, McAlpine JB, Vollmer G, Bosland MC, Nikolić D, Lankin DC, Chen SN, Bolton JL, Pauli GF, Dietz BM. Hitzman R, et al. Among authors: bosland mc. Phytochemistry. 2023 Oct;214:113789. doi: 10.1016/j.phytochem.2023.113789. Epub 2023 Jul 21. Phytochemistry. 2023. PMID: 37482264 Free PMC article.
172 results